by Elec23 | Oct 18, 2024 | News&events
VisMederi is pleased to announce the publishing of a collaborative study with GVGH (GSK Vaccines Institute for Global Health) that highlights a significant achievement in vaccine research. This recent study, published in Frontiers in Immunology, describes the creation...
by Elec23 | Oct 8, 2024 | News&events
For those wishing to fully immerse themselves in the serological techniques required by regulatory agencies including the FDA, EMA, and PMD for the licensing and approval of viral vaccines, a 12-week program has been developed by Trialect and VisMederi Foundation....
